Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NOW advanced for three days, in 237 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on NOW as a result. In 61 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for NOW just turned positive on October 09, 2026. Looking at past instances where NOW's MACD turned positive, the stock continued to rise in 37 of 54 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day RSI Indicator for NOW moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 21 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
NOW broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NOW entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. NOW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.648) is normal, around the industry mean (-1.402). P/E Ratio (95.106) is within average values for comparable stocks, (14.914). Projected Growth (PEG Ratio) (0.947) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (9.891) is also within normal values, averaging (71.128).
WEAV's Aroon Indicator triggered a bullish signal on October 19, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 231 similar instances where the Aroon Indicator showed a similar pattern. In 195 of the 231 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 84%.
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on WEAV as a result. In 71 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +0.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where WEAV advanced for three days, in 231 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 60 cases where WEAV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WEAV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
WEAV broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.997) is normal, around the industry mean (4.100). WEAV has a moderately low P/E Ratio (-27.370) as compared to the industry average of (13.263). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (2.228) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. WEAV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 43 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
NOW | ||
|---|---|---|
OUTLOOK RATING 1..100 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 90 | |
SMR RATING 1..100 | 59 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 64 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| NOW | WEAV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 62% | N/A |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 69% | N/A |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 76% |
| TrendMonth ODDS (%) | 2 days ago 66% | 2 days ago 80% |
| Advances ODDS (%) | 2 days ago 70% | 25 days ago 80% |
| Declines ODDS (%) | 10 days ago 70% | 18 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 84% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NOW’s FA Score shows that 0 FA rating(s) are green while WEAV’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NOW’s TA Score shows that 3 TA indicator(s) are bullish while WEAV’s TA Score has 3 bullish TA indicator(s).
NOW (@Packaged Software) experienced а +9.39% price change this week, while WEAV (@Services to the Health Industry) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.43%. For the same industry, the average monthly price growth was -3.98%, and the average quarterly price growth was +4.31%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
NOW is expected to report earnings on Oct 28, 2026.
WEAV is expected to report earnings on Oct 29, 2026.
Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.